PCCA encodes the biotin-containing alpha subunit of mitochondrial propionyl-CoA carboxylase (PCC; EC 6.4.1.3), a biotin-dependent carboxylase of the mitochondrial matrix. PCC catalyses the first, committed, ATP-dependent step of propionyl-CoA catabolism, converting propanoyl-CoA + bicarbonate + ATP into (S)-methylmalonyl-CoA + ADP + phosphate; the methylmalonyl-CoA product is subsequently converted to succinyl-CoA and enters the tricarboxylic acid cycle. Propionyl-CoA arises from the catabolism of the amino acids isoleucine, valine, methionine and threonine, of odd-chain fatty acids, and of cholesterol. The functional holoenzyme is a large alpha6-beta6 dodecamer (~750 kDa) built from six PCCA (alpha) and six PCCB (beta) subunits. The alpha subunit carries the biotin carboxylase (BC) domain and the C-terminal biotin-carboxyl-carrier-protein (BCCP) domain to which biotin is covalently attached (at Lys694, by holocarboxylase synthetase); it binds ATP and bicarbonate and catalyses the Mg2+-dependent carboxylation of biotin, whereas the beta subunit (PCCB) supplies the carboxyltransferase activity that transfers the carboxyl group to propionyl-CoA. The alpha subunit is synthesized with a cleavable N-terminal mitochondrial targeting presequence and matures in the matrix. Loss of PCC activity through biallelic pathogenic variants in PCCA (or PCCB) causes propionic acidemia, an autosomal recessive organic acidemia.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004658
propionyl-CoA carboxylase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred propionyl-CoA carboxylase activity. This is the core, defining molecular function of PCCA as the biotin-containing alpha subunit of the PCC holoenzyme, directly supported by biochemistry and disease genetics.
Reason: Well-supported core function; the IBA is at the correct level of specificity and concordant with experimental (IDA/IMP) annotations and the EC 6.4.1.3 assignment.
Supporting Evidence:
PMID:29033250
Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation of propionyl-CoA to methylmalonyl-CoA and is encoded by the genes PCCA and PCCB to form a hetero-dodecamer.
|
|
GO:0005739
mitochondrion
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred mitochondrial localization/activity. Correct: PCC is a mitochondrial matrix enzyme.
Reason: Consistent with experimental matrix localization (below); mitochondrion is a correct, if less specific, compartment for where the enzyme is active.
Supporting Evidence:
PMID:20725044
Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotin-dependent enzyme, is essential for the catabolism of the amino acids Thr, Val, Ile and Met, cholesterol and fatty acids with an odd number of carbon atoms.
|
|
GO:0004658
propionyl-CoA carboxylase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic (RHEA:23720 / EC 6.4.1.3 mapping) assignment of propionyl-CoA carboxylase activity. Redundant with, and confirmed by, the experimental IDA/IMP annotations of the same term.
Reason: Correct core molecular function; the EC/RHEA mapping matches the demonstrated catalytic activity.
Supporting Evidence:
PMID:6765947
We have purified propionyl-CoA carboxylase from normal, postmortem human liver to homogeneity.
|
|
GO:0005524
ATP binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based ATP binding. The alpha subunit contains an ATP-grasp domain and catalyses the ATP-dependent carboxylation of biotin; ATP is a substrate of the BC reaction (Km ~0.08 mM).
Reason: Supported by the catalytic mechanism, the ATP-grasp domain, and multiple ATP binding-site features in UniProt; ATP binding is integral to the alpha-subunit biotin carboxylase step.
Supporting Evidence:
PMID:6765947
The apparent Km values for ATP, propionyl-CoA, and bicarbonate are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
|
|
GO:0005759
mitochondrial matrix
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic (UniProt subcellular location / ARBA) assignment of mitochondrial matrix. Correct and concordant with experimental EXP/IDA matrix annotations.
Reason: PCC is a matrix enzyme; the electronic assignment matches the curated UniProt subcellular location and experimental evidence.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
|
|
GO:0009374
biotin binding
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ARBA electronic assignment of biotin binding. Biotin is the obligate cofactor of PCC and is covalently attached to the C-terminal biotinyl domain of the alpha subunit; each holoenzyme carries biotin almost entirely on the alpha subunit.
Reason: Strongly supported: biotin is the defining cofactor of this biotin-dependent carboxylase and is carried by PCCA.
Supporting Evidence:
PMID:6765947
Each mole of native enzyme contains 4 mol of bound biotin, virtually all of which is found with the larger (alpha) subunit.
|
|
GO:0016885
ligase activity, forming carbon-carbon bonds
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ARBA electronic assignment of the parent ligase term. This is the correct broad catalytic class (EC 6.4 ligases forming C-C bonds) for propionyl-CoA carboxylase, but is less informative than the specific GO:0004658 already annotated.
Reason: Correct parent activity; not wrong, but subsumed by the more specific propionyl-CoA carboxylase activity. Retained as a valid, if general, IEA.
Supporting Evidence:
PMID:29033250
Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation of propionyl-CoA to methylmalonyl-CoA
|
|
GO:0046872
metal ion binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based metal ion binding. The alpha-subunit biotin carboxylase/ATP-grasp domain binds two divalent metal ions (Mg2+ or Mn2+) per subunit that are required for the ATP-dependent carboxylation step.
Reason: Supported by UniProt cofactor annotation (binds 2 Mg2+/Mn2+ per subunit) and metal-binding site features; a general but correct molecular function.
Supporting Evidence:
PMID:20725044
The active site of the BC domain is conserved with that of E. coli BC, and all the residues that interact with the substrates of this reaction have essentially the same conformation in both structures
|
|
GO:0005515
protein binding
|
IPI
PMID:20725044 Crystal structure of the alpha(6)beta(6) holoenzyme of propi... |
MARK AS OVER ANNOTATED |
Summary: IntAct-curated binary interaction with PCCB (P05166), the beta subunit. This is the genuine, obligate holoenzyme partnership (alpha6-beta6), but the bare "protein binding" term is uninformative about the actual molecular function.
Reason: Per curation policy, bare protein binding IPIs are not removed. The interaction itself (with PCCB) is real and biologically central, but "protein binding" adds no functional specificity beyond what is captured by the propionyl-CoA carboxylase complex membership; a more informative term (structural constituent of the PCC holoenzyme) would be preferable.
Supporting Evidence:
PMID:20725044
The holoenzyme of PCC is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: IntAct/HuRI systematic binary interactome hit, here with MCC (MCCC1, P23508), a paralogous biotin-dependent carboxylase. Bare "protein binding" from a high-throughput all-by-all screen.
Reason: Uninformative term from a proteome-scale Y2H screen; not the core function. Retained per policy (not removed) but flagged as over-annotation.
Supporting Evidence:
PMID:32296183
Here we present a human 'all-by-all' reference interactome map of human binary protein interactions, or 'HuRI'.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: IntAct-curated interaction with PCCB (P05166) from a proteome-scale interactome study (BioPlex-type). Again the genuine beta-subunit partner, reported via the uninformative "protein binding" term.
Reason: Real interaction (PCCB, the holoenzyme partner) but bare protein binding is not the core molecular function; retained per policy and flagged as over-annotation.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MARK AS OVER ANNOTATED |
Summary: IntAct-curated interaction with PCCB (P05166) from a multimodal cell-map / genomics study. The beta-subunit partner again, via bare "protein binding".
Reason: Genuine PCCB partnership but uninformative term; retained per policy and flagged as over-annotation rather than removed.
Supporting Evidence:
PMID:40205054
Multimodal cell maps as a foundation for structural and functional genomics.
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Immunofluorescence (Human Protein Atlas) localization to mitochondrion. Correct, if less specific than the matrix annotations.
Reason: Direct localization evidence consistent with PCC being a mitochondrial matrix enzyme.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
|
|
GO:0005759
mitochondrial matrix
|
NAS
PMID:29033250 Propionyl-CoA carboxylase - A review. |
ACCEPT |
Summary: ComplexPortal (CPX-6169) NAS assignment of mitochondrial matrix, from the PCC review. Correct compartment for the holoenzyme.
Reason: Concordant with experimental EXP/IDA matrix evidence and the curated UniProt subcellular location.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
|
|
GO:0006631
fatty acid metabolic process
|
NAS
PMID:29033250 Propionyl-CoA carboxylase - A review. |
KEEP AS NON CORE |
Summary: ComplexPortal NAS: PCC participates in fatty acid metabolism, since propionyl-CoA is the end product of beta-oxidation of odd-chain fatty acids and PCC channels it into the TCA cycle. Broad process term.
Reason: Real but non-core physiological context. PCC acts on the propionyl-CoA node of odd-chain fatty acid catabolism; the direct reaction is more precisely propionyl-CoA carboxylation/propionate catabolism than generic fatty acid metabolism.
Supporting Evidence:
PMID:29033250
Disruption of PCC leads to accumulation of odd-chain fatty acids (FA), as propionyl-CoA is the end product of beta oxidation of odd-numbered FA.
|
|
GO:0009081
branched-chain amino acid metabolic process
|
NAS
PMID:29033250 Propionyl-CoA carboxylase - A review. |
KEEP AS NON CORE |
Summary: ComplexPortal NAS: PCC is downstream in the catabolism of branched-chain and other amino acids (isoleucine, valine, methionine, threonine) that generate propionyl-CoA.
Reason: Valid physiological role (Ile and Val catabolism converge on propionyl-CoA), but not the direct reaction PCCA catalyses; kept as a relevant non-core process. Note GO:0009081 covers isoleucine/leucine/valine; PCC also serves Met/Thr, which are not branched-chain, so this term is a partial view of PCC's amino-acid role.
Supporting Evidence:
PMID:29033250
Propionyl-CoA is produced by catabolism of cholesterol, valine, odd chain fatty acids, methionine, isoleucine and threonine
|
|
GO:1902494
catalytic complex
|
IPI
PMID:20725044 Crystal structure of the alpha(6)beta(6) holoenzyme of propi... |
ACCEPT |
Summary: ComplexPortal IPI: PCCA is part of a catalytic complex, i.e. the alpha6-beta6 PCC holoenzyme (ComplexPortal CPX-6169, Mitochondrial propionyl-CoA carboxylase complex).
Reason: Correct: PCCA is an obligate structural subunit of the catalytic PCC holoenzyme. A dedicated "propionyl-CoA carboxylase complex" GO term does not currently exist (only acetyl-CoA and methylcrotonoyl-CoA carboxylase complexes), so the general "catalytic complex" is retained rather than modified to a nonexistent term.
Supporting Evidence:
PMID:20725044
The holoenzyme of PCC is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
|
|
GO:0005759
mitochondrial matrix
|
EXP
PMID:10101253 Genetic heterogeneity in propionic acidemia patients with al... |
ACCEPT |
Summary: Experimental import/localization: in vitro-expressed PCCA precursor is imported into mitochondria and processed to the mature matrix form. Supports mitochondrial matrix localization.
Reason: Direct experimental evidence for mitochondrial import and maturation, consistent with the matrix location of the enzyme.
Supporting Evidence:
PMID:10101253
Both wild-type and mutant proteins were imported into mitochondria and processed into the mature form with similar efficiency
|
|
GO:1901290
succinyl-CoA biosynthetic process
|
IDA
PMID:8434582 Cloning of functional alpha propionyl CoA carboxylase and co... |
KEEP AS NON CORE |
Summary: IDA (propionate-flux complementation) linking PCCA to production of succinyl-CoA. PCC catalyses the first step (propionyl-CoA -> methylmalonyl-CoA); succinyl-CoA is the downstream product of the three-step propanoyl-CoA degradation pathway.
Reason: PCC's direct product is (S)-methylmalonyl-CoA, not succinyl-CoA; succinyl-CoA formation requires the downstream MCEE and MUT steps. The annotation reflects PCCA's contribution to the pathway output rather than its direct catalytic product, so it is kept as non-core.
Supporting Evidence:
PMID:8434582
Both clones reconstitute propionate flux to normal levels in fibroblasts from patients genetically deficient in PCCA (pccA).
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
ACCEPT |
Summary: High-throughput mitochondrial proteomics assignment to mitochondrion. Concordant with the established mitochondrial matrix localization.
Reason: High-confidence mitochondrial proteome evidence consistent with the curated compartment; correct though less specific than matrix.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics
|
|
GO:0005759
mitochondrial matrix
|
IDA
PMID:16023992 Mitochondrial targeting signals and mature peptides of 3-met... |
ACCEPT |
Summary: Direct evidence: the mature PCCA amino-terminus and cleavable N-terminal targeting presequence were defined, showing import into the mitochondrial matrix by the classical presequence pathway.
Reason: Experimental determination of the mitochondrial targeting signal and mature matrix peptide directly supports matrix localization.
Supporting Evidence:
PMID:16023992
the two subunits of the enzyme (MCCalpha; MCCbeta) are imported into the mitochondrial matrix by the classical pathway involving cleavable amino-terminal targeting presequences.
|
|
GO:0004658
propionyl-CoA carboxylase activity
|
IDA
PMID:6765947 Isolation and characterization of propionyl-CoA carboxylase ... |
ACCEPT |
Summary: Direct biochemical demonstration: PCC purified from human liver to homogeneity, shown to be a biotin-containing alpha/beta enzyme carboxylating propionyl-CoA with defined kinetic parameters. Core molecular function.
Reason: Definitive experimental evidence for propionyl-CoA carboxylase activity; anchors this as the core function of the enzyme.
Supporting Evidence:
PMID:6765947
The apparent Km values for ATP, propionyl-CoA, and bicarbonate are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
|
|
GO:0019626
short-chain fatty acid catabolic process
|
IC
PMID:6765947 Isolation and characterization of propionyl-CoA carboxylase ... |
MODIFY |
Summary: Curator inference (from GO:0004658) that PCC participates in short-chain fatty acid catabolism. Propionate/propionyl-CoA is a short-chain acid, but a more precise process term is available.
Reason: The reaction PCC catalyses is specifically the committed step of propionyl-CoA catabolism; "short-chain fatty acid catabolic process" is broader and less accurate than the dedicated term. Propose replacement with propionyl-CoA catabolic process.
Proposed replacements:
propionyl-CoA catabolic process
Supporting Evidence:
PMID:29033250
PCC's primary function is to catalyze the carboxylation of propionyl-CoA to produce methylmalonyl-CoA
|
|
GO:0019626
short-chain fatty acid catabolic process
|
IC
PMID:8434582 Cloning of functional alpha propionyl CoA carboxylase and co... |
MODIFY |
Summary: Second curator inference (from GO:0004658) of short-chain fatty acid catabolism, based on the propionate-flux complementation study. Same over-broad term as above.
Reason: As above, the direct process is propionyl-CoA / propionate catabolism; replace the broad short-chain fatty acid term with the specific propionyl-CoA catabolic process.
Proposed replacements:
propionyl-CoA catabolic process
Supporting Evidence:
PMID:8434582
Both clones reconstitute propionate flux to normal levels in fibroblasts from patients genetically deficient in PCCA (pccA).
|
|
GO:0004658
propionyl-CoA carboxylase activity
|
IMP
PMID:8434582 Cloning of functional alpha propionyl CoA carboxylase and co... |
ACCEPT |
Summary: IMP: recombinant human PCCA rescues (complements) the propionate-flux defect in PCCA-deficient (pccA) patient fibroblasts, demonstrating that PCCA is required for propionyl-CoA carboxylase activity in cells. Core molecular function.
Reason: Genetic complementation directly ties PCCA to the propionyl-CoA carboxylase activity and propionate flux; strong support for the core function.
Supporting Evidence:
PMID:8434582
We describe cDNA clones expressing human PCCA and complementation of the genetic defect in pccA fibroblasts by DNA-mediated gene transfer.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-2993447 |
KEEP AS NON CORE |
Summary: Reactome TAS placing PCCA in the cytosol, reflecting the pre-import apo-precursor and the Reactome "HLCS biotinylates 6x(PCCA:PCCB)" / cytosolic-to-matrix translocation events. PCC is not catalytically active in the cytosol.
Reason: The functional, biotinylated, active holoenzyme resides in the mitochondrial matrix; the cytosolic assignment reflects the transient apo-precursor stage before mitochondrial import (any cytosolic biotinylation is likely non-functional). Kept as a non-core, transient localization rather than removed.
Supporting Evidence:
PMID:29033250
The PCCA precursor does not contain biotin until imported into the mitochondrion and cleaved
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3323111 |
KEEP AS NON CORE |
Summary: Reactome TAS (cytosolic carboxylases translocate to mitochondrial matrix) placing the PCCA precursor in the cytosol prior to import.
Reason: As above: transient pre-import cytosolic localization of the apo-precursor; the active enzyme is a matrix enzyme. Non-core.
Supporting Evidence:
PMID:29033250
The PCCA precursor does not contain biotin until imported into the mitochondrion and cleaved
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9035990 |
KEEP AS NON CORE |
Summary: Reactome TAS (defective HLCS does not biotinylate 6x(PCCA:PCCB)) placing PCCA in the cytosol as part of the biotinylation/multiple-carboxylase-deficiency pathway.
Reason: Same transient cytosolic apo-precursor context; not the functional compartment. Kept as non-core.
Supporting Evidence:
PMID:29033250
The PCCA precursor does not contain biotin until imported into the mitochondrion and cleaved
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-3065959 |
ACCEPT |
Summary: Reactome TAS assignment of mitochondrial matrix (from the carboxylase degradation reaction). Correct functional compartment.
Reason: Concordant with experimental matrix evidence; the mature active enzyme is in the matrix.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-3323111 |
ACCEPT |
Summary: Reactome TAS assignment of mitochondrial matrix (post-translocation destination in the cytosol->matrix translocation reaction). Correct functional compartment.
Reason: Matches the established matrix localization of the mature enzyme.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-71031 |
ACCEPT |
Summary: Reactome TAS assignment of mitochondrial matrix, associated with the core PCC reaction (propionyl-CoA + CO2 + ATP <=> D-methylmalonyl-CoA + ADP + Pi). This is the compartment where the catalytic reaction occurs.
Reason: Correct: the propionyl-CoA carboxylase reaction takes place in the mitochondrial matrix.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
|
|
GO:0019899
enzyme binding
|
IPI
PMID:19157941 N- and C-terminal domains in human holocarboxylase synthetas... |
KEEP AS NON CORE |
Summary: IPI interaction with holocarboxylase synthetase (HLCS, P50747), the enzyme that covalently attaches biotin to PCCA. The study used the PCCA-derived C-terminal p67 polypeptide (biotinylation site K669/K694) as the HLCS substrate in Y2H and docking assays, defining the PCCA-HLCS substrate-enzyme interaction.
Reason: A real and biologically meaningful interaction (PCCA is the substrate of HLCS- mediated biotinylation, essential for activity), but it describes a post-translational modification relationship rather than PCCA's own core molecular function. "Enzyme binding" is more informative than bare protein binding, so it is retained as non-core.
Supporting Evidence:
PMID:19157941
The polypeptide p67 comprises the 67 C-terminal amino acids in human PCC (GenBank accession #AAA60035), including the biotin-binding site K669
|
|
GO:0009374
biotin binding
|
TAS
PMID:3460076 Isolation of cDNA clones coding for the alpha and beta chain... |
ACCEPT |
Summary: TAS (ProtInc) biotin binding, from the cDNA-cloning paper that identified the alpha chain via its conserved Ala-Met-Lys-Met biotin-binding-site motif. Biotin is the obligate cofactor carried by PCCA.
Reason: Well-established core cofactor relationship; the alpha chain was in fact identified through its biotin-binding-site sequence.
Supporting Evidence:
PMID:3460076
One class contained the anticipated Ala-Met-Lys-Met sequence, corresponding to the biotin binding site found in several biotin-dependent carboxylases, thus confirming the alpha-chain assignment of these clones.
|
Q: Do the three PCCA splice isoforms (P05165-1/-2/-3) differ in enzymatic function, holoenzyme incorporation, or tissue distribution? Their functional impact has not been well characterized.
Q: Does PCCA (or the PCC holoenzyme) have any moonlighting or regulatory role beyond carboxylation, e.g. via its reported acetylation/succinylation and interactions with SIRT3/4/5?
Experiment: Isoform-resolved enzyme kinetics and holoenzyme-assembly assays for P05165-2 and P05165-3 versus the canonical isoform, to determine whether alternative splicing alters propionyl-CoA carboxylase activity.
Experiment: Quantitative biotinylation/acylation site mapping of PCCA in matched control and propionic-acidemia cells to test how post-translational modification state modulates PCC activity.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Gene: PCCA | UniProt: P05165 | EC: 6.4.1.3 | Organism: Homo sapiens
The PCCA gene (HGNC:8653) is located on human chromosome 13 and encodes the alpha (Ξ±) subunit of propionyl-CoA carboxylase (PCC), a biotin-dependent mitochondrial enzyme (kelson1996chaperoninmediatedassemblyof pages 1-2). The Ξ± subunit has a molecular mass of approximately 70 kDa and is synthesized as a precursor protein containing an N-terminal mitochondrial targeting presequence of approximately 25 amino acids, which is proteolytically cleaved upon import into the mitochondrial matrix, yielding a mature protein beginning at residue 26 (kelson1996chaperoninmediatedassemblyof pages 2-3, kelson1996chaperoninmediatedassemblyof pages 1-2). The gene product functions together with the Ξ² subunit (encoded by PCCB) to form the active holoenzyme.
The following table summarizes the key properties of PCCA:
| Property | Summary |
|---|---|
| Gene name | PCCA; encodes the mitochondrial propionyl-CoA carboxylase alpha chain in human, matching UniProt accession P05165 (kelson1996chaperoninmediatedassemblyof pages 1-2) |
| UniProt accession | P05165 (user-provided target context) |
| Chromosomal location | Chromosome 13 in human (kelson1996chaperoninmediatedassemblyof pages 1-2) |
| Protein size | ~70 kDa alpha subunit of PCC (kelson1996chaperoninmediatedassemblyof pages 1-2) |
| Enzyme classification | EC 6.4.1.3, propionyl-CoA carboxylase (erdal2025aminoacidmetabolism pages 9-10, kelson1996chaperoninmediatedassemblyof pages 1-2) |
| Cofactor | Biotin; PCC is a biotin-dependent carboxylase (erdal2025aminoacidmetabolism pages 9-10, jitrapakdee2003thebiotinenzyme pages 4-6) |
| Reaction catalyzed | Propionyl-CoA + HCO3β + ATP β D-methylmalonyl-CoA + ADP + Pi; ATP-dependent biotin-mediated carboxylation (erdal2025aminoacidmetabolism pages 9-10, kelson1996chaperoninmediatedassemblyof pages 1-2, zhou2024structuralinsightsinto pages 4-6) |
| Subcellular localization | Mitochondrial matrix (kelson1996chaperoninmediatedassemblyof pages 1-2) |
| Mitochondrial targeting | Synthesized as a precursor with an N-terminal mitochondrial leader/presequence; mature alpha subunit begins at about residue 26, implying a ~25 aa targeting peptide (kelson1996chaperoninmediatedassemblyof pages 2-3, kelson1996chaperoninmediatedassemblyof pages 1-2) |
| Holoenzyme assembly | Ξ±6Ξ²6 dodecamer; four-layer architecture with six Ξ² subunits forming the core and Ξ± subunits arranged on top and bottom (kelson1996chaperoninmediatedassemblyof pages 1-2, zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4) |
| Key domains | Alpha/PCCA: BC (biotin carboxylase), BT linker/hub domain, BCCP (biotin carboxyl carrier protein); Beta/PCCB: CT (carboxyltransferase) domain with CT-N and CT-C subdomains (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4, jitrapakdee2003thebiotinenzyme pages 4-6) |
| Primary metabolic pathway | Propionate metabolism: propionyl-CoA β D-methylmalonyl-CoA β L-methylmalonyl-CoA β succinyl-CoA, which enters the TCA cycle and supports gluconeogenesis (erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9) |
| Metabolic inputs to pathway | Propionyl-CoA arises from catabolism of isoleucine, valine, threonine, methionine, odd-chain fatty acids, and cholesterol side chains (kelson1996chaperoninmediatedassemblyof pages 1-2, erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9) |
| Disease association | Biallelic loss-of-function variants in PCCA cause propionic acidemia, a severe autosomal recessive organic acidemia with metabolic decompensation, neurologic disease, and cardiomyopathy risk (maines2023understandingthepathogenesis pages 1-2, riverabarahona2018identificationof34 pages 1-5) |
| Substrate specificity | Primary substrate: propionyl-CoA. Human PCC can also carboxylate acetyl-CoA at a much lower rate, about 1.5% of the propionyl-CoA rate; recent structural work found acetyl-CoA and propionyl-CoA bind in highly similar modes (zhou2024structuralinsightsinto pages 6-7, jitrapakdee2003thebiotinenzyme pages 10-11) |
| Representative recent structural data | High-resolution human PCC cryo-EM structures reported in 2024: apo 3.02 Γ , propionyl-CoA-bound 2.80 Γ , with overall structures reported in the 2.29β3.38 Γ range; PDB entries include 8XL3, 8XL4, 8XL5 (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 11-14, zhou2024structuralinsightsinto pages 9-11) |
Table: This table summarizes the core molecular, biochemical, structural, and disease-related properties of human PCCA/propionyl-CoA carboxylase alpha chain. It is useful as a compact reference for functional annotation and for linking enzyme function to propionic acidemia.
PCC catalyzes the ATP-dependent, biotin-mediated carboxylation of propionyl-CoA to produce D-methylmalonyl-CoA, using bicarbonate (HCOββ») as the COβ donor (erdal2025aminoacidmetabolism pages 9-10, kelson1996chaperoninmediatedassemblyof pages 1-2). This reaction (EC 6.4.1.3) proceeds via a two-step mechanism characteristic of all biotin-dependent carboxylases:
Step 1 β Biotin carboxylation (in the BC domain of the Ξ± subunit): ATP activates bicarbonate to form a carboxyphosphate intermediate, which then transfers its carboxyl group to the N1β² atom of the covalently attached biotin prosthetic group (zhou2024structuralinsightsinto pages 4-6).
Step 2 β Carboxyl transfer (in the CT domain of the Ξ² subunit): The carboxylated biotin swings from the BC domain to the CT domain, where the carboxyl group is transferred to the C-Ξ± of propionyl-CoA, generating D-methylmalonyl-CoA. This process involves decarboxylation of carboxybiotin to produce free COβ and activated biotin, followed by deprotonation of the acyl moiety to attack the COβ (zhou2024structuralinsightsinto pages 4-6).
PCC exhibits strong selectivity for propionyl-CoA as its primary substrate. However, recent cryo-EM structural analyses have demonstrated that PCC can also carboxylate acetyl-CoA, albeit at a dramatically reduced rateβapproximately 1.5% of the propionyl-CoA carboxylation rate (zhou2024structuralinsightsinto pages 6-7). Structural studies revealed that propionyl-CoA and acetyl-CoA bind to PCC with nearly identical binding modes, indicating that the acyl-CoA specificity is largely attributable to subtle differences in interactions mediated by the acyl groups, although these differences were not fully resolved in the available cryo-EM densities (zhou2024structuralinsightsinto pages 6-7, zhou2024structuralinsightsinto pages 4-6). The carboxyltransferase domains of PCC, acetyl-CoA carboxylase, and 3-methylcrotonyl-CoA carboxylase show no sequence identity, underscoring the uniqueness of each enzyme's substrate binding site (jitrapakdee2003thebiotinenzyme pages 10-11).
The PCCA-encoded Ξ± subunit contains three functional domains arranged from N- to C-terminus (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4, jitrapakdee2003thebiotinenzyme pages 4-6):
Biotin carboxylase (BC) domain: Located at the N-terminus, this domain contains the ATP-grasp fold and catalyzes the first half-reactionβthe ATP-dependent carboxylation of the covalently attached biotin cofactor using bicarbonate as the COβ source.
BT (BC-CT interaction) domain: An intermediate hub domain that mediates interactions between the BC and CT functional regions.
Biotin carboxyl carrier protein (BCCP) domain: Located at the C-terminus, this domain contains the conserved lysine residue to which biotin is covalently attached via an amide bond. The BCCP domain positions the biotinyl group adjacent to the acyl-CoA binding pocket in the CT domain.
The Ξ² subunit (encoded by PCCB) consists solely of the carboxyltransferase (CT) domain, which is divided into CT-N and CT-C subdomains. The CT domain catalyzes the second half-reactionβtransfer of the carboxyl group from carboxybiotin to propionyl-CoA (zhou2024structuralinsightsinto pages 4-6).
The PCC holoenzyme assembles as an Ξ±βΞ²β dodecamer with a distinctive four-layer architecture: six Ξ² subunits form the core in two layers, with six Ξ± subunits positioned at the top and bottom in two additional layers. Each Ξ± subunit binds to one Ξ² subunit (kelson1996chaperoninmediatedassemblyof pages 1-2, zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4). The assembly of the holoenzyme requires molecular chaperones; studies in E. coli expression systems demonstrated that chaperonin (GroEL/GroES) facilitates proper folding and assembly of both wild-type and mutant PCC subunits (kelson1996chaperoninmediatedassemblyof pages 1-2).
A major structural advance came in 2024, when Zhou et al. reported the first high-resolution cryo-EM structures of human PCC holoenzyme in multiple states: the apo form at 3.02 Γ resolution, the propionyl-CoA-bound form (PCC-PCO) at 2.80 Γ resolution, and the acetyl-CoA-bound form (PCC-ACO) at 3.38 Γ resolution. These structures have been deposited in the Protein Data Bank (PDB entries 8XL3, 8XL4, 8XL5) (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 11-14, zhou2024structuralinsightsinto pages 9-11). Notably, in all PCC structures analyzed, the covalently linked biotin binds to an exo-site distant (>7 Γ ) from the catalytic residues G437 and A438 in the CT domain, suggesting the enzyme was captured in a catalytically incompetent conformation (zhou2024structuralinsightsinto pages 6-7).
PCC functions exclusively in the mitochondrial matrix, where it processes propionyl-CoA generated from multiple catabolic pathways (kelson1996chaperoninmediatedassemblyof pages 1-2). Both the Ξ± and Ξ² subunit precursors contain N-terminal mitochondrial matrix targeting presequences. The Ξ± subunit precursor undergoes proteolytic cleavage at a conserved motif for mitochondrial-targeted protein processing, with the mature Ξ± subunit beginning at approximately residue 26 (kelson1996chaperoninmediatedassemblyof pages 2-3). When expressed with its full-length sequence including the mitochondrial leader in mammalian cells, the Ξ² subunit precursor is correctly transported to mitochondria, confirming the functionality of the targeting sequence (kelson1996chaperoninmediatedassemblyof pages 1-2).
PCC occupies a critical position in the propionate catabolism pathway, catalyzing the first committed step in the conversion of propionyl-CoA to succinyl-CoA, a TCA cycle intermediate (erdal2025aminoacidmetabolism pages 9-10). The complete pathway proceeds as follows:
Succinyl-CoA then enters the TCA cycle and can support gluconeogenesis (erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9).
Propionyl-CoA is generated from multiple metabolic sources (kelson1996chaperoninmediatedassemblyof pages 1-2, erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9):
The liver is the dominant organ for propionyl-CoA metabolism, with kidney and pancreas also possessing significant metabolic capacity (lu2026lossofpropionylcoa pages 1-5). In healthy individuals, efficient hepatic propionate metabolism maintains low circulating propionate levels (0.4β5 Β΅M) (chen2025elevatedpropionateand pages 2-3).
Studies using CRISPR-edited PCCA-null HepG2 cells have revealed that PCCA deficiency causes widespread metabolic reprogramming beyond simple propionyl-CoA accumulation (lu2026lossofpropionylcoa pages 5-8, lu2026lossofpropionylcoa pages 1-5, lu2026lossofpropionylcoa pages 8-11):
Propionic acidemia (PA; OMIM #606054) is an autosomal recessive inborn error of metabolism caused by biallelic mutations in either PCCA or PCCB, resulting in deficient PCC enzyme activity (maines2023understandingthepathogenesis pages 1-2, riverabarahona2018identificationof34 pages 1-5). The clinical presentation includes:
The pathophysiology of PA extends beyond simple metabolite toxicity and involves multiple cellular pathways (maines2023understandingthepathogenesis pages 1-2, maines2023understandingthepathogenesis pages 4-5, chen2025elevatedpropionateand pages 3-4):
The following table summarizes current and emerging therapeutic strategies for propionic acidemia:
| Therapy type | Mechanism | Development stage | Key findings |
|---|---|---|---|
| Conventional management: dietary protein restriction, carnitine supplementation, metronidazole/other antibiotics | Reduces propiogenic substrate load from isoleucine, valine, methionine, threonine and lowers gut microbiota-derived propionate; carnitine promotes formation/excretion of propionylcarnitine and helps maintain carnitine pools | Standard of care / established clinical management | Current treatment is mainly supportive rather than curative. Dietary restriction, carnitine, and metronidazole/antibiotics are widely used and have improved survival, but many patients still develop chronic complications including neurologic and cardiac disease despite metabolic management (riverabarahona2018identificationof34 pages 1-5, erdal2025aminoacidmetabolism pages 9-10) |
| Liver transplantation | Provides a major new source of functional hepatic PCC activity, increasing systemic propionyl-CoA clearance and reducing recurrent metabolic instability | Established option for selected severe patients | Considered for severe disease; can stabilize metabolic control and may improve or reverse cardiomyopathy in some patients, but does not fully cure extrahepatic disease and is limited by transplant eligibility and risks (maines2023understandingthepathogenesis pages 1-2, maines2023understandingthepathogenesis pages 13-14) |
| mRNA-3927 dual mRNA-LNP therapy (encodes PCCA and PCCB) | Intravenous lipid nanoparticle delivery of therapeutic mRNAs to liver cells, enabling translation of both PCC subunits and reconstitution of active PCC enzyme | Clinical; first-in-human Phase 1/2 with interim results published in Nature (2024) | In 16 participants across 5 dose cohorts, 346 IV doses were administered over 15.69 person-years with no dose-limiting toxicities. Among 8 participants with pretreatment metabolic decompensation events, treatment was associated with a 70% reduction in risk; biomarkers including 3-HP, 2-MC, propionylcarnitine, and n-propionylglycine generally decreased after treatment (koeberl2024interimanalysesof pages 1-2, koeberl2024interimanalysesof pages 2-3, koeberl2024interimanalysesof pages 5-6) |
| Antisense oligonucleotide therapy targeting PCCA pseudoexon | Splice-switching ASOs suppress aberrant pseudoexon inclusion in mutant PCCA pre-mRNA to restore normal splicing and rescue enzyme expression/activity | Preclinical / experimental personalized RNA therapy | Recent work demonstrated modulation of PCCA pseudoexon splicing as a plausible mutation-specific rescue strategy, highlighting pseudoexon activation as a therapeutically actionable mechanism in propionic acidemia (chen2025elevatedpropionateand pages 7-7) |
| Metabolic rerouting approaches | Diverts upstream propiogenic flux away from propionyl-CoA production, for example by genetically or pharmacologically reducing valine/isoleucine catabolic steps that feed propionate metabolism | Preclinical proof-of-concept | In zebrafish models of disorders of propionyl-CoA metabolism, proximal interruption of valine/isoleucine oxidation improved survival and reduced propionate-derived toxic metabolites, supporting metabolic rerouting as a candidate strategy for PA (chen2025elevatedpropionateand pages 7-7) |
Table: This table summarizes current and emerging therapeutic approaches for propionic acidemia associated with PCCA deficiency, spanning standard management, transplantation, RNA therapeutics, and experimental metabolic strategies. It is useful for comparing mechanism, maturity, and evidence across interventions.
The most significant recent therapeutic development for PA is the first-in-human phase 1/2 clinical trial of mRNA-3927, a dual mRNA therapy encapsulated in lipid nanoparticles (LNPs) that encodes both human PCCA and PCCB subunits. As reported in Nature in April 2024, the interim analysis enrolled 16 participants across 5 dose cohorts (0.30β0.90 mg/kg administered intravenously every 2β3 weeks) (koeberl2024interimanalysesof pages 1-2, koeberl2024interimanalysesof pages 2-3). Key findings include:
An innovative personalized therapeutic strategy involves splice-modulating antisense oligonucleotides (ASOs) targeting a PCCA pseudoexon. The c.1285-1416A>G variant in intron 14 of the PCCA gene activates a pseudoexon, and ASOs designed to suppress this aberrant splicing event have been shown to rescue normal PCCA mRNA expression and enzyme activity in cellular models (chen2025elevatedpropionateand pages 7-7).
PCC belongs to the ancient family of biotin-dependent carboxylases, which are widespread across all three domains of life. Phylogenomic analyses suggest that CoA-bearing-substrate carboxylases, including PCC, arose from an ancestral enzyme present in the last common ancestor of Bacteria that could carry out non-specific carboxylation of several CoA-bearing substrates. Eukaryotes most likely acquired their biotin-dependent carboxylases through the mitochondrial endosymbiosis, consistent with the exclusive mitochondrial localization of PCC in eukaryotic cells (jitrapakdee2003thebiotinenzyme pages 4-6). The conserved domain architectureβBC, BCCP, and CT domainsβis shared across PCC, acetyl-CoA carboxylase, 3-methylcrotonyl-CoA carboxylase, and pyruvate carboxylase, reflecting their common evolutionary origin, though the CT domains diverge to accommodate different substrate specificities (jitrapakdee2003thebiotinenzyme pages 4-6, jitrapakdee2003thebiotinenzyme pages 10-11).
PCCA encodes the Ξ± subunit of propionyl-CoA carboxylase, a biotin-dependent mitochondrial matrix enzyme that catalyzes the ATP-dependent carboxylation of propionyl-CoA to D-methylmalonyl-CoA (EC 6.4.1.3). This reaction is the first committed step in the conversion of propionyl-CoA to succinyl-CoA for entry into the TCA cycle. The enzyme functions as an Ξ±βΞ²β dodecamer, with the Ξ± subunit housing the biotin carboxylase and biotin carboxyl carrier protein domains, and the Ξ² subunit providing the carboxyltransferase domain. PCC is essential for the catabolism of branched-chain amino acids (isoleucine, valine), threonine, methionine, odd-chain fatty acids, and cholesterol side chains, as well as for clearance of gut-derived propionate. Loss-of-function mutations in PCCA cause propionic acidemia, a severe inborn error of metabolism with multisystem complications including neurological damage, cardiomyopathy, and recurrent metabolic crises. Recent high-resolution cryo-EM structures (2024) have provided unprecedented structural insights, and the landmark mRNA-3927 clinical trial has demonstrated the feasibility of dual mRNA replacement therapy for this devastating disorder.
References
(kelson1996chaperoninmediatedassemblyof pages 1-2): T. L. Kelson, T. Ohura, and J. Kraus. Chaperonin-mediated assembly of wild-type and mutant subunits of human propionyl-coa carboxylase expressed in escherichia coli. Human molecular genetics, 5 3:331-7, Mar 1996. URL: https://doi.org/10.1093/hmg/5.3.331, doi:10.1093/hmg/5.3.331. This article has 37 citations and is from a domain leading peer-reviewed journal.
(kelson1996chaperoninmediatedassemblyof pages 2-3): T. L. Kelson, T. Ohura, and J. Kraus. Chaperonin-mediated assembly of wild-type and mutant subunits of human propionyl-coa carboxylase expressed in escherichia coli. Human molecular genetics, 5 3:331-7, Mar 1996. URL: https://doi.org/10.1093/hmg/5.3.331, doi:10.1093/hmg/5.3.331. This article has 37 citations and is from a domain leading peer-reviewed journal.
(erdal2025aminoacidmetabolism pages 9-10): Ranya Erdal, KΔ±vanΓ§ Birsoy, and Gokhan Unlu. Amino acid metabolism in liver mitochondria: from homeostasis to disease. Metabolites, 15:446, Jul 2025. URL: https://doi.org/10.3390/metabo15070446, doi:10.3390/metabo15070446. This article has 7 citations.
(jitrapakdee2003thebiotinenzyme pages 4-6): Sarawut Jitrapakdee and John Wallace. The biotin enzyme family: conserved structural motifs and domain rearrangements. Jun 2003. URL: https://doi.org/10.2174/1389203033487199, doi:10.2174/1389203033487199. This article has 142 citations and is from a peer-reviewed journal.
(zhou2024structuralinsightsinto pages 4-6): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.
(zhou2024structuralinsightsinto pages 1-4): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.
(erdal2025aminoacidmetabolism pages 6-9): Ranya Erdal, KΔ±vanΓ§ Birsoy, and Gokhan Unlu. Amino acid metabolism in liver mitochondria: from homeostasis to disease. Metabolites, 15:446, Jul 2025. URL: https://doi.org/10.3390/metabo15070446, doi:10.3390/metabo15070446. This article has 7 citations.
(maines2023understandingthepathogenesis pages 1-2): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.
(riverabarahona2018identificationof34 pages 1-5): Ana Rivera-Barahona, Rosa Navarrete, Raquel GarcΓa-RodrΓguez, Eva Richard, Magdalena Ugarte, Celia PΓ©rez-Cerda, BelΓ©n PΓ©rez, Alejandra GΓ‘mez, and Lourdes R. Desviat. Identification of 34 novel mutations in propionic acidemia: functional characterization of missense variants and phenotype associations. Molecular genetics and metabolism, 125 3:266-275, Nov 2018. URL: https://doi.org/10.1016/j.ymgme.2018.09.008, doi:10.1016/j.ymgme.2018.09.008. This article has 29 citations and is from a peer-reviewed journal.
(zhou2024structuralinsightsinto pages 6-7): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.
(jitrapakdee2003thebiotinenzyme pages 10-11): Sarawut Jitrapakdee and John Wallace. The biotin enzyme family: conserved structural motifs and domain rearrangements. Jun 2003. URL: https://doi.org/10.2174/1389203033487199, doi:10.2174/1389203033487199. This article has 142 citations and is from a peer-reviewed journal.
(zhou2024structuralinsightsinto pages 11-14): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.
(zhou2024structuralinsightsinto pages 9-11): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.
(lu2026lossofpropionylcoa pages 1-5): Fang Lu, Chorlada Paiboonrungruang, Wentao He, Zhaohui Xiong, Pingchuan Tang, Takhar Kasumov, Xiaoxin Chen, and Guo-Fang Zhang. Loss of propionyl-coa carboxylase reprograms hepatic metabolism by suppressing mitochondrial pyruvate carboxylation and fatty acid oxidation. bioRxiv, Apr 2026. URL: https://doi.org/10.64898/2026.04.13.718201, doi:10.64898/2026.04.13.718201. This article has 0 citations.
(chen2025elevatedpropionateand pages 2-3): Xiaoxin Chen, Qing Cheng, and Guo-Fang Zhang. Elevated propionate and its association with neurological dysfunctions in propionic acidemia. Frontiers in Molecular Neuroscience, Mar 2025. URL: https://doi.org/10.3389/fnmol.2025.1499376, doi:10.3389/fnmol.2025.1499376. This article has 11 citations.
(lu2026lossofpropionylcoa pages 5-8): Fang Lu, Chorlada Paiboonrungruang, Wentao He, Zhaohui Xiong, Pingchuan Tang, Takhar Kasumov, Xiaoxin Chen, and Guo-Fang Zhang. Loss of propionyl-coa carboxylase reprograms hepatic metabolism by suppressing mitochondrial pyruvate carboxylation and fatty acid oxidation. bioRxiv, Apr 2026. URL: https://doi.org/10.64898/2026.04.13.718201, doi:10.64898/2026.04.13.718201. This article has 0 citations.
(lu2026lossofpropionylcoa pages 8-11): Fang Lu, Chorlada Paiboonrungruang, Wentao He, Zhaohui Xiong, Pingchuan Tang, Takhar Kasumov, Xiaoxin Chen, and Guo-Fang Zhang. Loss of propionyl-coa carboxylase reprograms hepatic metabolism by suppressing mitochondrial pyruvate carboxylation and fatty acid oxidation. bioRxiv, Apr 2026. URL: https://doi.org/10.64898/2026.04.13.718201, doi:10.64898/2026.04.13.718201. This article has 0 citations.
(chen2025elevatedpropionateand pages 3-4): Xiaoxin Chen, Qing Cheng, and Guo-Fang Zhang. Elevated propionate and its association with neurological dysfunctions in propionic acidemia. Frontiers in Molecular Neuroscience, Mar 2025. URL: https://doi.org/10.3389/fnmol.2025.1499376, doi:10.3389/fnmol.2025.1499376. This article has 11 citations.
(maines2023understandingthepathogenesis pages 4-5): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.
(chen2025elevatedpropionateand pages 7-7): Xiaoxin Chen, Qing Cheng, and Guo-Fang Zhang. Elevated propionate and its association with neurological dysfunctions in propionic acidemia. Frontiers in Molecular Neuroscience, Mar 2025. URL: https://doi.org/10.3389/fnmol.2025.1499376, doi:10.3389/fnmol.2025.1499376. This article has 11 citations.
(maines2023understandingthepathogenesis pages 11-13): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.
(maines2023understandingthepathogenesis pages 13-14): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.
(koeberl2024interimanalysesof pages 1-2): Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, and Stephanie Grunewald. Interim analyses of a first-in-human phase 1/2 mrna trial for propionic acidaemia. Nature, 628:872-877, Apr 2024. URL: https://doi.org/10.1038/s41586-024-07266-7, doi:10.1038/s41586-024-07266-7. This article has 136 citations and is from a highest quality peer-reviewed journal.
(koeberl2024interimanalysesof pages 2-3): Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, and Stephanie Grunewald. Interim analyses of a first-in-human phase 1/2 mrna trial for propionic acidaemia. Nature, 628:872-877, Apr 2024. URL: https://doi.org/10.1038/s41586-024-07266-7, doi:10.1038/s41586-024-07266-7. This article has 136 citations and is from a highest quality peer-reviewed journal.
(koeberl2024interimanalysesof pages 5-6): Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, and Stephanie Grunewald. Interim analyses of a first-in-human phase 1/2 mrna trial for propionic acidaemia. Nature, 628:872-877, Apr 2024. URL: https://doi.org/10.1038/s41586-024-07266-7, doi:10.1038/s41586-024-07266-7. This article has 136 citations and is from a highest quality peer-reviewed journal.
just deep-research-falcon human P05165 / uv run scripts/deep_research_wrapper.py
did NOT produce a PCCA-deep-research-falcon.md (falcon wrapper: system python 3.9
chokes on dict | None; run via uv started but produced no output/log within the
poll window). Per instructions I did NOT fabricate a -deep-research-*.md. Grounded
this review in PCCA-uniprot.txt, the seeded GOA, dismech/kb/disorders/Propionic_Acidemia.yaml,
and the cached publications/PMID_*.md.
PCCA = biotin-containing alpha subunit of mitochondrial propionyl-CoA carboxylase (PCC),
a biotin-dependent carboxylase. PCC catalyses the first committed, ATP-dependent step of
propionyl-CoA catabolism: propanoyl-CoA + HCO3- + ATP -> (S)-methylmalonyl-CoA + ADP + Pi
(EC 6.4.1.3; RHEA:23720). Holoenzyme = alpha6beta6 dodecamer (~750 kDa) of PCCA (alpha) +
PCCB (beta) [PMID:20725044, PMID:29033250].
Biallelic PCCA (or PCCB) loss-of-function -> propionic acidemia (PA-1, MIM:606054;
MONDO:0011628) [UniProt DISEASE; PMID:10101253; disorder KB]. Autosomal recessive organic
acidemia; toxic organic acid accumulation, metabolic acidosis, hyperammonemia.
id: P05165
gene_symbol: PCCA
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
PCCA encodes the biotin-containing alpha subunit of mitochondrial propionyl-CoA
carboxylase (PCC; EC 6.4.1.3), a biotin-dependent carboxylase of the mitochondrial
matrix. PCC catalyses the first, committed, ATP-dependent step of propionyl-CoA
catabolism, converting propanoyl-CoA + bicarbonate + ATP into (S)-methylmalonyl-CoA
+ ADP + phosphate; the methylmalonyl-CoA product is subsequently converted to
succinyl-CoA and enters the tricarboxylic acid cycle. Propionyl-CoA arises from the
catabolism of the amino acids isoleucine, valine, methionine and threonine, of
odd-chain fatty acids, and of cholesterol. The functional holoenzyme is a large
alpha6-beta6 dodecamer (~750 kDa) built from six PCCA (alpha) and six PCCB (beta)
subunits. The alpha subunit carries the biotin carboxylase (BC) domain and the
C-terminal biotin-carboxyl-carrier-protein (BCCP) domain to which biotin is
covalently attached (at Lys694, by holocarboxylase synthetase); it binds ATP and
bicarbonate and catalyses the Mg2+-dependent carboxylation of biotin, whereas the
beta subunit (PCCB) supplies the carboxyltransferase activity that transfers the
carboxyl group to propionyl-CoA. The alpha subunit is synthesized with a cleavable
N-terminal mitochondrial targeting presequence and matures in the matrix. Loss of
PCC activity through biallelic pathogenic variants in PCCA (or PCCB) causes propionic
acidemia, an autosomal recessive organic acidemia.
alternative_products:
- name: '1'
id: P05165-1
- name: '2'
id: P05165-2
sequence_note: VSP_039857
- name: '3'
id: P05165-3
sequence_note: VSP_044458
existing_annotations:
- term:
id: GO:0004658
label: propionyl-CoA carboxylase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetically inferred propionyl-CoA carboxylase activity. This is the core,
defining molecular function of PCCA as the biotin-containing alpha subunit of the
PCC holoenzyme, directly supported by biochemistry and disease genetics.
action: ACCEPT
reason: >-
Well-supported core function; the IBA is at the correct level of specificity and
concordant with experimental (IDA/IMP) annotations and the EC 6.4.1.3 assignment.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation
of propionyl-CoA to methylmalonyl-CoA and is encoded by the genes PCCA and PCCB
to form a hetero-dodecamer.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetically inferred mitochondrial localization/activity. Correct: PCC is a
mitochondrial matrix enzyme.
action: ACCEPT
reason: >-
Consistent with experimental matrix localization (below); mitochondrion is a
correct, if less specific, compartment for where the enzyme is active.
supported_by:
- reference_id: PMID:20725044
supporting_text: >-
Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotin-dependent enzyme,
is essential for the catabolism of the amino acids Thr, Val, Ile and Met,
cholesterol and fatty acids with an odd number of carbon atoms.
- term:
id: GO:0004658
label: propionyl-CoA carboxylase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (RHEA:23720 / EC 6.4.1.3 mapping) assignment of propionyl-CoA
carboxylase activity. Redundant with, and confirmed by, the experimental IDA/IMP
annotations of the same term.
action: ACCEPT
reason: >-
Correct core molecular function; the EC/RHEA mapping matches the demonstrated
catalytic activity.
supported_by:
- reference_id: PMID:6765947
supporting_text: >-
We have purified propionyl-CoA carboxylase from normal, postmortem human liver
to homogeneity.
- term:
id: GO:0005524
label: ATP binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-based ATP binding. The alpha subunit contains an ATP-grasp domain and
catalyses the ATP-dependent carboxylation of biotin; ATP is a substrate of the BC
reaction (Km ~0.08 mM).
action: ACCEPT
reason: >-
Supported by the catalytic mechanism, the ATP-grasp domain, and multiple ATP
binding-site features in UniProt; ATP binding is integral to the alpha-subunit
biotin carboxylase step.
supported_by:
- reference_id: PMID:6765947
supporting_text: >-
The apparent Km values for ATP, propionyl-CoA, and bicarbonate
are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: >-
Electronic (UniProt subcellular location / ARBA) assignment of mitochondrial
matrix. Correct and concordant with experimental EXP/IDA matrix annotations.
action: ACCEPT
reason: >-
PCC is a matrix enzyme; the electronic assignment matches the curated UniProt
subcellular location and experimental evidence.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
id: GO:0009374
label: biotin binding
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
ARBA electronic assignment of biotin binding. Biotin is the obligate cofactor of
PCC and is covalently attached to the C-terminal biotinyl domain of the alpha
subunit; each holoenzyme carries biotin almost entirely on the alpha subunit.
action: ACCEPT
reason: >-
Strongly supported: biotin is the defining cofactor of this biotin-dependent
carboxylase and is carried by PCCA.
supported_by:
- reference_id: PMID:6765947
supporting_text: >-
Each mole of native enzyme
contains 4 mol of bound biotin, virtually all of which is found with the larger
(alpha) subunit.
- term:
id: GO:0016885
label: ligase activity, forming carbon-carbon bonds
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
ARBA electronic assignment of the parent ligase term. This is the correct broad
catalytic class (EC 6.4 ligases forming C-C bonds) for propionyl-CoA carboxylase,
but is less informative than the specific GO:0004658 already annotated.
action: ACCEPT
reason: >-
Correct parent activity; not wrong, but subsumed by the more specific
propionyl-CoA carboxylase activity. Retained as a valid, if general, IEA.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation
of propionyl-CoA to methylmalonyl-CoA
- term:
id: GO:0046872
label: metal ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-based metal ion binding. The alpha-subunit biotin carboxylase/ATP-grasp
domain binds two divalent metal ions (Mg2+ or Mn2+) per subunit that are required
for the ATP-dependent carboxylation step.
action: ACCEPT
reason: >-
Supported by UniProt cofactor annotation (binds 2 Mg2+/Mn2+ per subunit) and
metal-binding site features; a general but correct molecular function.
supported_by:
- reference_id: PMID:20725044
supporting_text: >-
The active site of the BC domain is conserved with that of E. coli BC, and all
the residues that interact with the substrates of this reaction have essentially
the same conformation in both structures
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20725044
qualifier: enables
review:
summary: >-
IntAct-curated binary interaction with PCCB (P05166), the beta subunit. This is
the genuine, obligate holoenzyme partnership (alpha6-beta6), but the bare
"protein binding" term is uninformative about the actual molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Per curation policy, bare protein binding IPIs are not removed. The interaction
itself (with PCCB) is real and biologically central, but "protein binding" adds no
functional specificity beyond what is captured by the propionyl-CoA carboxylase
complex membership; a more informative term (structural constituent of the PCC
holoenzyme) would be preferable.
supported_by:
- reference_id: PMID:20725044
supporting_text: >-
The holoenzyme of PCC
is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
IntAct/HuRI systematic binary interactome hit, here with MCC (MCCC1, P23508), a
paralogous biotin-dependent carboxylase. Bare "protein binding" from a
high-throughput all-by-all screen.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative term from a proteome-scale Y2H screen; not the core function.
Retained per policy (not removed) but flagged as over-annotation.
supported_by:
- reference_id: PMID:32296183
supporting_text: >-
Here we present a human 'all-by-all'
reference interactome map of human binary protein interactions, or 'HuRI'.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
IntAct-curated interaction with PCCB (P05166) from a proteome-scale interactome
study (BioPlex-type). Again the genuine beta-subunit partner, reported via the
uninformative "protein binding" term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Real interaction (PCCB, the holoenzyme partner) but bare protein binding is not
the core molecular function; retained per policy and flagged as over-annotation.
supported_by:
- reference_id: PMID:33961781
supporting_text: Dual proteome-scale networks reveal cell-specific remodeling of the human
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
qualifier: enables
review:
summary: >-
IntAct-curated interaction with PCCB (P05166) from a multimodal cell-map / genomics
study. The beta-subunit partner again, via bare "protein binding".
action: MARK_AS_OVER_ANNOTATED
reason: >-
Genuine PCCB partnership but uninformative term; retained per policy and flagged
as over-annotation rather than removed.
supported_by:
- reference_id: PMID:40205054
supporting_text: Multimodal cell maps as a foundation for structural and functional genomics.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: >-
Immunofluorescence (Human Protein Atlas) localization to mitochondrion. Correct,
if less specific than the matrix annotations.
action: ACCEPT
reason: >-
Direct localization evidence consistent with PCC being a mitochondrial matrix
enzyme.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: NAS
original_reference_id: PMID:29033250
qualifier: located_in
review:
summary: >-
ComplexPortal (CPX-6169) NAS assignment of mitochondrial matrix, from the PCC
review. Correct compartment for the holoenzyme.
action: ACCEPT
reason: >-
Concordant with experimental EXP/IDA matrix evidence and the curated UniProt
subcellular location.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
id: GO:0006631
label: fatty acid metabolic process
evidence_type: NAS
original_reference_id: PMID:29033250
qualifier: involved_in
review:
summary: >-
ComplexPortal NAS: PCC participates in fatty acid metabolism, since propionyl-CoA
is the end product of beta-oxidation of odd-chain fatty acids and PCC channels it
into the TCA cycle. Broad process term.
action: KEEP_AS_NON_CORE
reason: >-
Real but non-core physiological context. PCC acts on the propionyl-CoA node of
odd-chain fatty acid catabolism; the direct reaction is more precisely
propionyl-CoA carboxylation/propionate catabolism than generic fatty acid
metabolism.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
Disruption of PCC leads to accumulation of odd-chain fatty acids (FA), as
propionyl-CoA is the end product of beta oxidation of odd-numbered FA.
- term:
id: GO:0009081
label: branched-chain amino acid metabolic process
evidence_type: NAS
original_reference_id: PMID:29033250
qualifier: involved_in
review:
summary: >-
ComplexPortal NAS: PCC is downstream in the catabolism of branched-chain and other
amino acids (isoleucine, valine, methionine, threonine) that generate propionyl-CoA.
action: KEEP_AS_NON_CORE
reason: >-
Valid physiological role (Ile and Val catabolism converge on propionyl-CoA), but
not the direct reaction PCCA catalyses; kept as a relevant non-core process.
Note GO:0009081 covers isoleucine/leucine/valine; PCC also serves Met/Thr, which
are not branched-chain, so this term is a partial view of PCC's amino-acid role.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
Propionyl-CoA is produced by catabolism of cholesterol, valine, odd chain fatty
acids, methionine, isoleucine and threonine
- term:
id: GO:1902494
label: catalytic complex
evidence_type: IPI
original_reference_id: PMID:20725044
qualifier: part_of
review:
summary: >-
ComplexPortal IPI: PCCA is part of a catalytic complex, i.e. the alpha6-beta6 PCC
holoenzyme (ComplexPortal CPX-6169, Mitochondrial propionyl-CoA carboxylase complex).
action: ACCEPT
reason: >-
Correct: PCCA is an obligate structural subunit of the catalytic PCC holoenzyme.
A dedicated "propionyl-CoA carboxylase complex" GO term does not currently exist
(only acetyl-CoA and methylcrotonoyl-CoA carboxylase complexes), so the general
"catalytic complex" is retained rather than modified to a nonexistent term.
supported_by:
- reference_id: PMID:20725044
supporting_text: >-
The holoenzyme of PCC
is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: EXP
original_reference_id: PMID:10101253
qualifier: located_in
review:
summary: >-
Experimental import/localization: in vitro-expressed PCCA precursor is imported
into mitochondria and processed to the mature matrix form. Supports mitochondrial
matrix localization.
action: ACCEPT
reason: >-
Direct experimental evidence for mitochondrial import and maturation, consistent
with the matrix location of the enzyme.
supported_by:
- reference_id: PMID:10101253
supporting_text: >-
Both wild-type and mutant proteins were imported into
mitochondria and processed into the mature form with similar efficiency
- term:
id: GO:1901290
label: succinyl-CoA biosynthetic process
evidence_type: IDA
original_reference_id: PMID:8434582
qualifier: involved_in
review:
summary: >-
IDA (propionate-flux complementation) linking PCCA to production of succinyl-CoA.
PCC catalyses the first step (propionyl-CoA -> methylmalonyl-CoA); succinyl-CoA is
the downstream product of the three-step propanoyl-CoA degradation pathway.
action: KEEP_AS_NON_CORE
reason: >-
PCC's direct product is (S)-methylmalonyl-CoA, not succinyl-CoA; succinyl-CoA
formation requires the downstream MCEE and MUT steps. The annotation reflects
PCCA's contribution to the pathway output rather than its direct catalytic
product, so it is kept as non-core.
supported_by:
- reference_id: PMID:8434582
supporting_text: >-
Both
clones reconstitute propionate flux to normal levels in fibroblasts from
patients genetically deficient in PCCA (pccA).
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
qualifier: located_in
review:
summary: >-
High-throughput mitochondrial proteomics assignment to mitochondrion. Concordant
with the established mitochondrial matrix localization.
action: ACCEPT
reason: >-
High-confidence mitochondrial proteome evidence consistent with the curated
compartment; correct though less specific than matrix.
supported_by:
- reference_id: PMID:34800366
supporting_text: Quantitative high-confidence human mitochondrial proteome and its dynamics
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IDA
original_reference_id: PMID:16023992
qualifier: located_in
review:
summary: >-
Direct evidence: the mature PCCA amino-terminus and cleavable N-terminal targeting
presequence were defined, showing import into the mitochondrial matrix by the
classical presequence pathway.
action: ACCEPT
reason: >-
Experimental determination of the mitochondrial targeting signal and mature matrix
peptide directly supports matrix localization.
supported_by:
- reference_id: PMID:16023992
supporting_text: >-
the two subunits of the enzyme (MCCalpha; MCCbeta)
are imported into the mitochondrial matrix by the classical pathway involving
cleavable amino-terminal targeting presequences.
- term:
id: GO:0004658
label: propionyl-CoA carboxylase activity
evidence_type: IDA
original_reference_id: PMID:6765947
qualifier: enables
review:
summary: >-
Direct biochemical demonstration: PCC purified from human liver to homogeneity,
shown to be a biotin-containing alpha/beta enzyme carboxylating propionyl-CoA with
defined kinetic parameters. Core molecular function.
action: ACCEPT
reason: >-
Definitive experimental evidence for propionyl-CoA carboxylase activity; anchors
this as the core function of the enzyme.
supported_by:
- reference_id: PMID:6765947
supporting_text: >-
The apparent Km values for ATP, propionyl-CoA, and bicarbonate
are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
- term:
id: GO:0019626
label: short-chain fatty acid catabolic process
evidence_type: IC
original_reference_id: PMID:6765947
qualifier: involved_in
review:
summary: >-
Curator inference (from GO:0004658) that PCC participates in short-chain fatty acid
catabolism. Propionate/propionyl-CoA is a short-chain acid, but a more precise
process term is available.
action: MODIFY
reason: >-
The reaction PCC catalyses is specifically the committed step of propionyl-CoA
catabolism; "short-chain fatty acid catabolic process" is broader and less
accurate than the dedicated term. Propose replacement with propionyl-CoA catabolic
process.
proposed_replacement_terms:
- id: GO:1902859
label: propionyl-CoA catabolic process
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
PCC's
primary function is to catalyze the carboxylation of propionyl-CoA to produce
methylmalonyl-CoA
- term:
id: GO:0019626
label: short-chain fatty acid catabolic process
evidence_type: IC
original_reference_id: PMID:8434582
qualifier: involved_in
review:
summary: >-
Second curator inference (from GO:0004658) of short-chain fatty acid catabolism,
based on the propionate-flux complementation study. Same over-broad term as above.
action: MODIFY
reason: >-
As above, the direct process is propionyl-CoA / propionate catabolism; replace the
broad short-chain fatty acid term with the specific propionyl-CoA catabolic process.
proposed_replacement_terms:
- id: GO:1902859
label: propionyl-CoA catabolic process
supported_by:
- reference_id: PMID:8434582
supporting_text: >-
Both
clones reconstitute propionate flux to normal levels in fibroblasts from
patients genetically deficient in PCCA (pccA).
- term:
id: GO:0004658
label: propionyl-CoA carboxylase activity
evidence_type: IMP
original_reference_id: PMID:8434582
qualifier: enables
review:
summary: >-
IMP: recombinant human PCCA rescues (complements) the propionate-flux defect in
PCCA-deficient (pccA) patient fibroblasts, demonstrating that PCCA is required for
propionyl-CoA carboxylase activity in cells. Core molecular function.
action: ACCEPT
reason: >-
Genetic complementation directly ties PCCA to the propionyl-CoA carboxylase
activity and propionate flux; strong support for the core function.
supported_by:
- reference_id: PMID:8434582
supporting_text: >-
We describe cDNA clones expressing
human PCCA and complementation of the genetic defect in pccA fibroblasts by
DNA-mediated gene transfer.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2993447
qualifier: located_in
review:
summary: >-
Reactome TAS placing PCCA in the cytosol, reflecting the pre-import apo-precursor
and the Reactome "HLCS biotinylates 6x(PCCA:PCCB)" / cytosolic-to-matrix
translocation events. PCC is not catalytically active in the cytosol.
action: KEEP_AS_NON_CORE
reason: >-
The functional, biotinylated, active holoenzyme resides in the mitochondrial
matrix; the cytosolic assignment reflects the transient apo-precursor stage before
mitochondrial import (any cytosolic biotinylation is likely non-functional). Kept
as a non-core, transient localization rather than removed.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
The PCCA precursor does not contain biotin until imported into the mitochondrion
and cleaved
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3323111
qualifier: located_in
review:
summary: >-
Reactome TAS (cytosolic carboxylases translocate to mitochondrial matrix) placing
the PCCA precursor in the cytosol prior to import.
action: KEEP_AS_NON_CORE
reason: >-
As above: transient pre-import cytosolic localization of the apo-precursor; the
active enzyme is a matrix enzyme. Non-core.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
The PCCA precursor does not contain biotin until imported into the mitochondrion
and cleaved
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9035990
qualifier: located_in
review:
summary: >-
Reactome TAS (defective HLCS does not biotinylate 6x(PCCA:PCCB)) placing PCCA in
the cytosol as part of the biotinylation/multiple-carboxylase-deficiency pathway.
action: KEEP_AS_NON_CORE
reason: >-
Same transient cytosolic apo-precursor context; not the functional compartment.
Kept as non-core.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
The PCCA precursor does not contain biotin until imported into the mitochondrion
and cleaved
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3065959
qualifier: located_in
review:
summary: >-
Reactome TAS assignment of mitochondrial matrix (from the carboxylase degradation
reaction). Correct functional compartment.
action: ACCEPT
reason: >-
Concordant with experimental matrix evidence; the mature active enzyme is in the
matrix.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3323111
qualifier: located_in
review:
summary: >-
Reactome TAS assignment of mitochondrial matrix (post-translocation destination in
the cytosol->matrix translocation reaction). Correct functional compartment.
action: ACCEPT
reason: >-
Matches the established matrix localization of the mature enzyme.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-71031
qualifier: located_in
review:
summary: >-
Reactome TAS assignment of mitochondrial matrix, associated with the core PCC
reaction (propionyl-CoA + CO2 + ATP <=> D-methylmalonyl-CoA + ADP + Pi). This is
the compartment where the catalytic reaction occurs.
action: ACCEPT
reason: >-
Correct: the propionyl-CoA carboxylase reaction takes place in the mitochondrial
matrix.
supported_by:
- reference_id: PMID:29033250
supporting_text: >-
It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
id: GO:0019899
label: enzyme binding
evidence_type: IPI
original_reference_id: PMID:19157941
qualifier: enables
review:
summary: >-
IPI interaction with holocarboxylase synthetase (HLCS, P50747), the enzyme that
covalently attaches biotin to PCCA. The study used the PCCA-derived C-terminal p67
polypeptide (biotinylation site K669/K694) as the HLCS substrate in Y2H and docking
assays, defining the PCCA-HLCS substrate-enzyme interaction.
action: KEEP_AS_NON_CORE
reason: >-
A real and biologically meaningful interaction (PCCA is the substrate of HLCS-
mediated biotinylation, essential for activity), but it describes a
post-translational modification relationship rather than PCCA's own core molecular
function. "Enzyme binding" is more informative than bare protein binding, so it is
retained as non-core.
supported_by:
- reference_id: PMID:19157941
supporting_text: >-
The polypeptide p67 comprises the 67 C-terminal amino acids in human PCC (GenBank
accession #AAA60035), including the biotin-binding site K669
- term:
id: GO:0009374
label: biotin binding
evidence_type: TAS
original_reference_id: PMID:3460076
qualifier: enables
review:
summary: >-
TAS (ProtInc) biotin binding, from the cDNA-cloning paper that identified the
alpha chain via its conserved Ala-Met-Lys-Met biotin-binding-site motif. Biotin is
the obligate cofactor carried by PCCA.
action: ACCEPT
reason: >-
Well-established core cofactor relationship; the alpha chain was in fact identified
through its biotin-binding-site sequence.
supported_by:
- reference_id: PMID:3460076
supporting_text: >-
One class contained the anticipated Ala-Met-Lys-Met
sequence, corresponding to the biotin binding site found in several
biotin-dependent carboxylases, thus confirming the alpha-chain assignment of
these clones.
core_functions:
- description: >-
Propionyl-CoA carboxylase alpha subunit: within the alpha6-beta6 PCC holoenzyme, the
alpha subunit binds ATP and bicarbonate and catalyses the Mg2+-dependent ATP-driven
carboxylation of its covalently bound biotin, contributing the biotin carboxylase
half-reaction of propionyl-CoA carboxylase activity (conversion of propanoyl-CoA to
(S)-methylmalonyl-CoA), the first committed step of propionyl-CoA / propionate
catabolism in the mitochondrial matrix.
molecular_function:
id: GO:0004658
label: propionyl-CoA carboxylase activity
directly_involved_in:
- id: GO:1902859
label: propionyl-CoA catabolic process
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:6765947
supporting_text: >-
The apparent Km values for ATP, propionyl-CoA, and bicarbonate
are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
- reference_id: PMID:29033250
supporting_text: >-
PCC's
primary function is to catalyze the carboxylation of propionyl-CoA to produce
methylmalonyl-CoA
- description: >-
Biotin cofactor carrier: the alpha subunit carries the C-terminal biotinyl (BCCP)
domain and binds biotin, which is covalently attached (by holocarboxylase synthetase)
and is obligately required for catalytic activity of the biotin-dependent carboxylase.
molecular_function:
id: GO:0009374
label: biotin binding
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:6765947
supporting_text: >-
Each mole of native enzyme
contains 4 mol of bound biotin, virtually all of which is found with the larger
(alpha) subunit.
- description: >-
ATP binding: the alpha subunit ATP-grasp/biotin carboxylase domain binds ATP (Km
~0.08 mM) as a substrate of the ATP-dependent biotin carboxylation step.
molecular_function:
id: GO:0005524
label: ATP binding
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:6765947
supporting_text: >-
The apparent Km values for ATP, propionyl-CoA, and bicarbonate
are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
proposed_new_terms: []
suggested_questions:
- question: >-
Do the three PCCA splice isoforms (P05165-1/-2/-3) differ in enzymatic function,
holoenzyme incorporation, or tissue distribution? Their functional impact has not
been well characterized.
- question: >-
Does PCCA (or the PCC holoenzyme) have any moonlighting or regulatory role beyond
carboxylation, e.g. via its reported acetylation/succinylation and interactions with
SIRT3/4/5?
suggested_experiments:
- description: >-
Isoform-resolved enzyme kinetics and holoenzyme-assembly assays for P05165-2 and
P05165-3 versus the canonical isoform, to determine whether alternative splicing
alters propionyl-CoA carboxylase activity.
- description: >-
Quantitative biotinylation/acylation site mapping of PCCA in matched control and
propionic-acidemia cells to test how post-translational modification state modulates
PCC activity.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10101253
title: Genetic heterogeneity in propionic acidemia patients with alpha-subunit defects.
Identification of five novel mutations, one of them causing instability of the
protein.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified; provides experimental mitochondrial import/maturation and
PA-causing PCCA variant data. Supports the EXP mitochondrial-matrix annotation.
- id: PMID:16023992
title: Mitochondrial targeting signals and mature peptides of 3-methylcrotonyl-CoA
carboxylase.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Focuses on MCC but the abstract explicitly reports the mitochondrial targeting
signal and mature N-terminus of propionyl-CoA carboxylase as a paralog; supports
the matrix-import IDA for PCCA.
- id: PMID:19157941
title: N- and C-terminal domains in human holocarboxylase synthetase participate
in substrate recognition.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Uses the PCCA-derived C-terminal p67 (biotinylation site) as the HLCS substrate;
documents the PCCA-HLCS enzyme-substrate interaction underlying the enzyme-binding
annotation.
- id: PMID:20725044
title: Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme
A carboxylase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Defines the alpha6-beta6 holoenzyme architecture, BC/BCCP/BT domains of the alpha
subunit, and BC active site; the source of the PCCB-interaction and catalytic-complex
annotations.
- id: PMID:29033250
title: Propionyl-CoA carboxylase - A review.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Authoritative review of PCC structure, function, mechanism, localization, and
disease; primary basis for the description and process/localization judgments.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
HuRI all-by-all binary interactome; source of a systematic PCCA-MCC(MCCC1) hit
reported as bare protein binding. Not informative about core function.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Proteome-scale interactome study; source of a PCCA-PCCB protein-binding hit. The
interaction (beta subunit) is genuine but the term is uninformative.
- id: PMID:3460076
title: 'Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA
carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA
and PCCB genes.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Identified the PCCA (alpha) cDNA via the conserved biotin-binding-site motif;
supports the biotin-binding TAS annotation.
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
High-confidence mitochondrial proteome; independent HTP evidence for mitochondrial
localization of PCCA.
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Multimodal cell-map genomics resource; source of a PCCA-PCCB protein-binding hit.
Genuine partner, uninformative term.
- id: PMID:6765947
title: Isolation and characterization of propionyl-CoA carboxylase from normal human
liver. Evidence for a protomeric tetramer of nonidentical subunits.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Definitive biochemical characterization of purified human PCC: biotin content on the
alpha subunit, kinetic parameters for ATP/propionyl-CoA/bicarbonate, substrate range.
Primary support for the catalytic-activity, cofactor and ATP-binding core functions.
- id: PMID:8434582
title: Cloning of functional alpha propionyl CoA carboxylase and correction of enzyme
deficiency in pccA fibroblasts.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Functional cloning and complementation of PCCA-deficient fibroblasts restoring
propionate flux; support for the IMP propionyl-CoA carboxylase and pathway annotations.
- id: Reactome:R-HSA-2993447
title: HLCS biotinylates 6x(PCCA:PCCB)
findings: []
- id: Reactome:R-HSA-3065959
title: An unknown protease degrades hCBXs
findings: []
- id: Reactome:R-HSA-3323111
title: Cytosolic carboxylases translocate to mitochondrial matrix
findings: []
- id: Reactome:R-HSA-71031
title: propionyl-CoA + CO2 + ATP <=> D-methylmalonyl-CoA + ADP + orthophosphate
findings: []
- id: Reactome:R-HSA-9035990
title: Defective HLCS does not biotinylate 6x(PCCA:PCCB)
findings: []